711378 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Homocitrullination of lysine residues mediated by myeloid-derived suppressor cells in the tumor environment is a target for cancer immunotherapy |
2021-07-01 |
10.1136/jitc-2020-001910 |
Cook Katherine W, Xue Wei, Symonds Peter, Daniels Ian, Gijon Mohamed, Boocock David, Coveney Clare, Miles Amanda K, Shah Sabaria, Atabani Suha, Choudhury Ruhul H, Vaghela Poonam, Weston Daisy, Metheringham Rachael L, Brentville Victoria A, Durrant Lindy G |
711377 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Statins act as transient type I interferon inhibitors to enable the antitumor activity of modified vaccinia Ankara viral vectors |
2021-07-01 |
10.1136/jitc-2020-001587 |
Tenesaca Shirley, Vasquez Marcos, Alvarez Maite, Otano Itziar, Fernandez-Sendin Myriam, Di Trani Claudia Augusta, Ardaiz Nuria, Gomar Celia, Bella Angela, Aranda Fernando, Medina-Echeverz José, Melero Ignacio, Berraondo Pedro |
711376 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors |
2021-07-01 |
10.1136/jitc-2021-002851 |
Brown Jacqueline T, Liu Yuan, Shabto Julie M, Martini Dylan, Ravindranathan Deepak, Hitron Emilie Elise, Russler Greta Anne, Caulfield Sarah, Yantorni Lauren, Joshi Shreyas Subhash, Kissick Haydn, Ogan Kenneth, Nazha Bassel, Carthon Bradley C, Kucuk Omer, Harris Wayne B, Master Viraj A, Bilen Mehmet Asim |
711375 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG m |
2021-07-01 |
10.1136/jitc-2020-002267 |
Chu Yaya, Nayyar Gaurav, Jiang Susiyan, Rosenblum Jeremy M., Soon-Shiong Patrick, Safrit Jeffrey T, Lee Dean A., Cairo Mitchell S. |
711374 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Determinants of response to daratumumab in Epstein-Barr virus-positive natural killer and T-cell lymphoma |
2021-07-01 |
10.1136/jitc-2020-002123 |
Mustafa Nurulhuda, Nee Adina Huey Fang, Chooi Jing Yuan, Toh Sabrina Hui Min, Chung Tae-Hoon, Selvarajan Viknesvaran, Fan Shuangyi, Ng Siok Bian, Poon Michelle, Chan Esther, Lee Joanne, Chee Yen Lin, Jeyasekharan Anand D, Zhou Longen, Yang Jennifer, Chng Wee Joo |
711373 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation |
2021-07-01 |
10.1136/jitc-2021-002852 |
Nakamura Takashi, Sato Takanori, Endo Rikito, Sasaki Shun, Takahashi Naomichi, Sato Yusuke, Hyodo Mamoru, Hayakawa Yoshihiro, Harashima Hideyoshi |
711372 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Search for effective treatments in patients with advanced refractory melanoma continues: can novel intratumoral therapies deliver? |
2021-07-01 |
10.1136/jitc-2021-002820 |
Najjar Yana G |
711371 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers |
2021-07-01 |
10.1136/jitc-2021-003044 |
Cunha Mateus Trinconi, Carvalho Vinicius Jardim, Loureiro Rafael Maffei, Brantis-de-Carvalho Carlos Eduardo, Cintra Murilo Bicudo, de Castro Junior Gilberto |
711370 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
First-in-human DR5 PET reveals insufficient DR5 expression in patients with gastrointestinal cancer |
2021-07-01 |
10.1136/jitc-2021-002926 |
Wang Shujing, Zhu Hua, Li Yingjie, Ding Jin, Wang Feng, Ding Lixin, Wang Xinyu, Zhao Jun, Zhang Yan, Yao Yunfeng, Zhou Tong, Li Nan, Wu Aiwen, Yang Zhi |
711369 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Neutrophils in the era of immune checkpoint blockade |
2021-07-01 |
10.1136/jitc-2020-002242 |
Faget Julien, Peters Solange, Quantin Xavier, Meylan Etienne, Bonnefoy Nathalie |